Veeva, an IT company that has been on a years-long march to develop a full range of cloud-based software for clinical research, held its annual R&D conference this week (Sept. 9-12) in Philadelphia, and both in leading up to the event and during it, provided updates on current software and market development.
At the meeting, the company announced an expanded version of Vault RIM (Regulatory Information Management) for medical devices, including support of industry standards such as Universal Device Identifier (UDI) and the submission standards of the International Medical Device Regulators Forum. Also, not long after Salesforce.com acquired Mulesoft, Veeva announced the MuleSoft Connector for Veeva Vault, a tailored solution for integrating Vault to third-party enterprise solutions. (Vault is the overall brand for Veeva’s cloud-based document and data management platform; additionally, Veeva’s software itself is built on the SalesForce.com platform.)
Meanwhile, the company has announced that 55 clinical research organizations (CROs) have adopted a variety of the company’s clinical offerings, including Vault RIM, Vault Quality and Vault CTMS (Clinical Trial Management System). The number of pharma companies using Vault CTMS has doubled in the past year, to 50. At the R&D conference, CEO Peter Gassner spoke to an eventual goal of connecting trial sponsors (e.g., pharma companies), CROs and clinical trial sites on a unified platform—something that is rarely, if ever, accomplished into today’s drug-development environment.